increased susceptibility to becterial infection 76.175.994.184.422.7 22.628.926616161610102030405060708090100Hb(g/L)Hct(%)EPO(100IU/w)治疗前(静脉组)治疗前(静脉组)治疗前(口服组)治疗前(口服组)治疗8 周(静脉组)治疗8 周(静脉组)治疗8 周(口服组)治疗8 周(口服组)2462655073510100200300400500600SF(ng/ml)21212222343427270 05 5101015152020252530303535TSAT(%)TSAT(%)治疗前(静脉组)治疗前(静脉组)治疗前(口服组)治疗前(口服组)治疗8 周(静脉组)治疗8 周(静脉组)治疗8 周(口服组)治疗8 周(口服组)